These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15841308)

  • 21. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture.
    Akao M; Hasebe Y; Okumura N; Hagiwara H; Seki T; Ariga T
    Thromb Res; 2002 Aug; 107(3-4):169-74. PubMed ID: 12431485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding.
    Gonzalez-Gronow M; Stack S; Pizzo SV
    Arch Biochem Biophys; 1991 May; 286(2):625-8. PubMed ID: 1654795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system.
    Aisina RB; Mukhametova LI; Gulin DA; Levashov MY; Prisyazhnaya NV; Gershkovich KB; Varfolomeyev SD
    Biochemistry (Mosc); 2009 Oct; 74(10):1104-13. PubMed ID: 19916923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen: an enigmatic zymogen.
    Keragala CB; Medcalf RL
    Blood; 2021 May; 137(21):2881-2889. PubMed ID: 33735914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial cell proteases: physiological role and regulation.
    Menashi S; Lu H; Soria C; Legrand Y
    Baillieres Clin Haematol; 1993 Sep; 6(3):559-76. PubMed ID: 7517736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.
    Sazonova IY; Robinson BR; Gladysheva IP; Castellino FJ; Reed GL
    J Biol Chem; 2004 Jun; 279(24):24994-5001. PubMed ID: 15069059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
    Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of omega-amino acids on plasminogen activation and fibrinolysis induced by staphylokinase.
    Levashov MY; Aisina RB; Gershkovich KB; Varfolomeyev SD
    Biochemistry (Mosc); 2007 Jul; 72(7):707-15. PubMed ID: 17680762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
    López-Alemany R; Suelves M; Muñoz-Cánoves P
    Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.